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Supplementary Table 1. Clearance and acquisition rates of pneumococcal serotypes in the Gambian infants. 
  
Serotype 
Clearance rate (per day) Time from birth to first 
acquisition in days (95% CI) 
Time from birth to reacquisition 
in days (95% CI) All episodes (95% CI) First episode (95% CI) Second episode (95% CI) 
6B 0.0116 (0.0072,0.0187) 0.0111 (0.0066,0.0187) 0.0153 (0.0049,0.0475) 0.0119 (0.007,0.02) 0.0067 (0.0022,0.0208) 
4 0.0159 (0.0066,0.0381) 0.0159 (0.0066,0.0381) – 0.0057 (0.0024,0.0136) – 
13 0.0168 (0.0113,0.0251) 0.0175 (0.0115,0.0265) – 0.0062 (0.0041,0.0095) – 
23F 0.0174 (0.0103,0.0294) 0.0169 (0.0094,0.0305) 0.0195 (0.0063,0.0604) 0.0095 (0.0052,0.0171) 0.0045 (0.0015,0.014) 
19A 0.0178 (0.0146,0.0217) 0.0157 (0.0125,0.0198) 0.0279 (0.019,0.041) 0.0075 (0.0059,0.0094) 0.0055 (0.0036,0.0085) 
9L 0.0185 (0.0111,0.0306) 0.0184 (0.0105,0.0325) 0.0186 (0.006,0.0578) 0.0101 (0.0057,0.0178) – 
20 0.0209 (0.0112,0.0388) 0.0177 (0.0089,0.0354) – 0.0086 (0.0043,0.0172) – 
39 0.0213 (0.0101,0.0446) 0.026 (0.0117,0.0578) – 0.0077 (0.0034,0.017) – 
35B 0.0215 (0.0148,0.0311) 0.0257 (0.0174,0.038) 0.0091 (0.0029,0.0283) 0.006 (0.004,0.0089) 0.0079 (0.0026,0.0246) 
21 0.0231 (0.0159,0.0334) 0.0239 (0.016,0.0356) 0.019 (0.0071,0.0508) 0.0085 (0.0057,0.0126) – 
6A 0.0232 (0.0185,0.0291) 0.0222 (0.0172,0.0286) 0.0282 (0.017,0.0468) 0.009 (0.007,0.0116) 0.005 (0.003,0.0085) 
11A 0.0241 (0.0164,0.0354) 0.0403 (0.0265,0.0612) 0.0075 (0.0028,0.02) 0.0059 (0.0039,0.009) 0.0048 (0.0018,0.0129) 
10A 0.0243 (0.0151,0.0391) 0.0223 (0.0135,0.037) – 0.0051 (0.0031,0.0084) – 
23B 0.0247 (0.0175,0.0349) 0.0288 (0.0197,0.042) 0.014 (0.0058,0.0336) 0.0088 (0.006,0.0128) 0.0058 (0.0024,0.0138) 
22A 0.026 (0.0148,0.0457) 0.0286 (0.0154,0.0531) – 0.0087 (0.0047,0.0162) – 
14 0.026 (0.0176,0.0384) 0.0284 (0.0181,0.0446) 0.0204 (0.0092,0.0454) 0.0083 (0.0053,0.0131) 0.0081 (0.0034,0.0195) 
16F 0.0271 (0.0182,0.0404) 0.0336 (0.0221,0.051) – 0.0065 (0.0043,0.0099) – 
15B/C 0.0276 (0.0204,0.0374) 0.031 (0.0223,0.043) 0.0168 (0.0076,0.0374) 0.0055 (0.004,0.0076) 0.004 (0.0018,0.0089) 
15A 0.028 (0.0176,0.0444) 0.0337 (0.021,0.0543) – 0.0068 (0.0043,0.011) – 
19F 0.0281 (0.0199,0.0395) 0.0286 (0.02,0.0409) 0.0238 (0.0077,0.0738) 0.0059 (0.0042,0.0085) 0.0043 (0.0014,0.0134) 
9A 0.0286 (0.0136,0.0599) 0.0286 (0.0136,0.0599) – 0.0085 (0.004,0.0178) – 
34 0.0293 (0.0206,0.0417) 0.0282 (0.0196,0.0406) – 0.0085 (0.0059,0.0123) – 
48 0.0306 (0.0138,0.0681) 0.0275 (0.0114,0.066) – 0.0143 (0.0059,0.0343) – 
18A 0.0312 (0.014,0.0694) 0.0312 (0.014,0.0694) – 0.0193 (0.0087,0.0429) – 
7F 0.0317 (0.0119,0.0846) 0.0317 (0.0119,0.0846) – 0.0053 (0.002,0.0142) – 
17F 0.0317 (0.0176,0.0573) 0.0314 (0.0169,0.0584) – 0.0051 (0.0027,0.0095) – 
9V 0.0336 (0.0168,0.0672) 0.0313 (0.0149,0.0656) – 0.0059 (0.0028,0.0124) – 
40 0.0342 (0.0189,0.0617) 0.0325 (0.0175,0.0603) – 0.0065 (0.0035,0.012) – 
12F 0.0357 (0.0179,0.0714) 0.0357 (0.0179,0.0714) – 0.0085 (0.0043,0.0171) – 
23A 0.0371 (0.0216,0.064) 0.0357 (0.0203,0.0629) – 0.0086 (0.0049,0.0152) – 
38 0.0378 (0.0197,0.0727) 0.0408 (0.0204,0.0816) – 0.0069 (0.0034,0.0138) – 
11B 0.0381 (0.0191,0.0762) 0.0357 (0.017,0.0749) – 0.0053 (0.0025,0.011) – 
3 0.0401 (0.0201,0.0802) 0.0571 (0.0272,0.1199) – 0.0086 (0.0041,0.018) – 
18C 0.0417 (0.0199,0.0874) 0.039 (0.0175,0.0867) – 0.0126 (0.0057,0.0281) – 
11D 0.0429 (0.0138,0.1329) 0.0429 (0.0138,0.1329) – 0.0055 (0.0018,0.017) – 
35F 0.0476 (0.0179,0.1269) 0.0476 (0.0179,0.1269) – 0.006 (0.0022,0.0159) – 
3 
NT 0.0505 (0.0382,0.0669) 0.0466 (0.0339,0.064) 0.0714 (0.0396,0.129) 0.0093 (0.0068,0.0128) 0.0043 (0.0024,0.0077) 
28F 0.0571 (0.0272,0.1199) 0.0571 (0.0272,0.1199) – 0.009 (0.0043,0.019) – 
8 0.0595 (0.0248,0.143) 0.0595 (0.0248,0.143) – 0.0089 (0.0037,0.0215) – 
9N 0.0625 (0.0298,0.1311) 0.0612 (0.0275,0.1363) – 0.0057 (0.0026,0.0127) – 
1 0.0635 (0.0318,0.127) 0.0635 (0.0318,0.127) – 0.0106 (0.0053,0.0212) – 
41 0.0714 (0.023,0.2215) – – – – 
19B 0.0714 (0.0268,0.1903) 0.0714 (0.0268,0.1903) – 0.0063 (0.0024,0.0167) – 
47 0.0714 (0.0268,0.1903) 0.0714 (0.023,0.2215) – 0.0102 (0.0033,0.0316) – 
47A 0.0714 (0.0268,0.1903) 0.0714 (0.0268,0.1903) – 0.0136 (0.0051,0.0363) – 
5 0.0714 (0.0268,0.1903) 0.0714 (0.0268,0.1903) – 0.0053 (0.002,0.0141) – 
10F 0.0714 (0.0297,0.1716) 0.0714 (0.0297,0.1716) – 0.0069 (0.0029,0.0167) – 
16A 0.0714 (0.0297,0.1716) 0.0714 (0.0297,0.1716) – 0.0038 (0.0016,0.009) – 
36 0.0714 (0.0321,0.159) 0.0714 (0.0321,0.159) – 0.0126 (0.0057,0.0281) – 
19C 0.0714 (0.0396,0.129) 0.0714 (0.0396,0.129) – 0.0047 (0.0026,0.0085) – 
47F 0.0779 (0.0251,0.2416) 0.0779 (0.0251,0.2416) – 0.007 (0.0022,0.0216) – 




 Supplementary Figure 1. Proportion of colonisation episodes associated with each 
serotype.
19A























































































Supplementary Figure 2. Clearance and acquisition rates of pneumococcal serotypes in 
Gambian infants. Graph showing (a) clearance rate, (b) initial acquisition rate of serotypes, (b) 
acquisition rate of the second serotype, (c) rates of acquisition of a serotype for the first and 






































































































































































































































































































































































Supplementary Figure 3. The Kaplan-Meier survival curves and exponential fit to the 
carriage duration data of each serotype. The plots show the overall duration from acquisition 
to clearance of each serotypes regardless of acquisition time. The black curve represents the 
Kaplan-Meier estimates while the yellow line is the fitted survival curve. The rate parameter in 
the exponential model is shown at the top of each plot represents the mean clearance rate whose 




Supplementary Figure 4. The Kaplan-Meier survival curves and exponential fit to the time 
to first acquisition data of each serotype. The plots show duration from birth of an infant to 
first acquisition of each serotype. The black curve represents the Kaplan-Meier estimates while 
the yellow line is the fitted survival curve. The rate parameter in the exponential model is shown 
at the top of each plot represents the mean acquisition rate whose inverse equates to mean the 
time to first acquisition of each serotype.
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Supplementary Figure 5. The Kaplan-Meier survival curves and exponential fit to the 
carriage duration data after first acquisition for each serotype. The plots show duration from 
first acquisition until clearance of each serotype. The black curve represents the Kaplan-Meier 
estimates while the yellow line is the fitted survival curve. The rate parameter in the exponential 
model is shown at the top of each plot represents the mean clearance rate after first episode whose 
inverse equates to mean the time to acquisition of each serotype.
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Supplementary Figure 6. The Kaplan-Meier survival curves and exponential fit to the time 
to second acquisition or reacquisition data for each serotype. The plots show duration from 
birth of an infant until second acquisition of each serotype. The black curve represents the 
Kaplan-Meier estimates while the yellow line is the fitted survival curve. The rate parameter in 
the exponential model is shown at the top of each plot represents the mean reacquisition rate after 
whose inverse equates to mean the time to reacquisition of each serotype.
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Supplementary Figure 7. The Kaplan-Meier survival curves and exponential fit to the 
carriage duration data after second acquisition or reacquisition for each serotype. The plots 
show duration from first acquisition until clearance of each serotype. The black curve represents 
the Kaplan-Meier estimates while the yellow line is the fitted survival curve. The rate parameter 
in the exponential model is shown at the top of each plot represents the mean clearance rate after 
first episode whose inverse equates to mean the time to acquisition of each serotype.
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Supplementary Figure 8. The Kaplan-Meier survival curves comparing the carriage 
duration of the first episode and second episode of serotypes acquired multiple times. The 




Supplementary Figure 9. The Kaplan-Meier survival curves comparing the carriage 
duration for each serotype in different communities. The infants in group 1 were from PCV-
unexposed (unvaccinated) communities and received PCV7 after 6 months. The infants in group 
2 were also from PCV-unexposed (unvaccinated) communities where the infants received PCV7 
at 2, 3 and 4 months. The infants from group 3 originated from PCV-exposed (vaccinated) 
communities and they received PCV7 at 2, 3 and 4 months. The P-values were calculated using 
the log-rank test. Only serotypes found in both communities in >3 colonisation episodes are 
shown in the figure.
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Supplementary Figure 10. The Kaplan-Meier survival curves comparing the time to 
acquisition for each serotype in different communities. The infants in community 1 were from 
PCV-unexposed (unvaccinated) villages and received PCV7 after 6 months. The infants in 
community 2 were also from PCV-unexposed (unvaccinated) villages where the infants received 
PCV7 at 2, 3 and 4 months. The infants from community 3 originated from PCV-exposed 
(vaccinated) villages and they received PCV7 at 2, 3 and 4 months. The P-values were calculated 
using the log-rank test. Only serotypes found in both communities in >3 colonisation episodes 
are shown in the figure. 
